Voyager Therapeutics (VYGR) Competitors $5.36 +0.09 (+1.71%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends VYGR vs. ADVM, JNCE, CASI, BLUE, AGTC, APLT, AVDL, ZYME, SEPN, and COGTShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Adverum Biotechnologies (ADVM), Jounce Therapeutics (JNCE), CASI Pharmaceuticals (CASI), bluebird bio (BLUE), Applied Genetic Technologies (AGTC), Applied Therapeutics (APLT), Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME), Septerna (SEPN), and Cogent Biosciences (COGT). These companies are all part of the "medical" sector. Voyager Therapeutics vs. Adverum Biotechnologies Jounce Therapeutics CASI Pharmaceuticals bluebird bio Applied Genetic Technologies Applied Therapeutics Avadel Pharmaceuticals Zymeworks Septerna Cogent Biosciences Adverum Biotechnologies (NASDAQ:ADVM) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Is ADVM or VYGR more profitable? Voyager Therapeutics has a net margin of 15.80% compared to Adverum Biotechnologies' net margin of 0.00%. Voyager Therapeutics' return on equity of 8.33% beat Adverum Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adverum BiotechnologiesN/A -65.14% -40.52% Voyager Therapeutics 15.80%8.33%6.15% Which has preferable earnings & valuation, ADVM or VYGR? Voyager Therapeutics has higher revenue and earnings than Adverum Biotechnologies. Adverum Biotechnologies is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdverum Biotechnologies$3.60M35.65-$117.17M-$5.99-1.03Voyager Therapeutics$250.01M1.17$132.33M$0.717.55 Does the MarketBeat Community prefer ADVM or VYGR? Voyager Therapeutics received 21 more outperform votes than Adverum Biotechnologies when rated by MarketBeat users. Likewise, 67.59% of users gave Voyager Therapeutics an outperform vote while only 60.39% of users gave Adverum Biotechnologies an outperform vote. CompanyUnderperformOutperformAdverum BiotechnologiesOutperform Votes36960.39% Underperform Votes24239.61% Voyager TherapeuticsOutperform Votes39067.59% Underperform Votes18732.41% Do insiders & institutionals believe in ADVM or VYGR? 48.2% of Adverum Biotechnologies shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 4.2% of Adverum Biotechnologies shares are held by insiders. Comparatively, 4.5% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts recommend ADVM or VYGR? Adverum Biotechnologies presently has a consensus price target of $27.83, suggesting a potential upside of 351.11%. Voyager Therapeutics has a consensus price target of $17.00, suggesting a potential upside of 217.16%. Given Adverum Biotechnologies' higher possible upside, research analysts clearly believe Adverum Biotechnologies is more favorable than Voyager Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adverum Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Voyager Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility & risk, ADVM or VYGR? Adverum Biotechnologies has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Does the media favor ADVM or VYGR? In the previous week, Voyager Therapeutics had 16 more articles in the media than Adverum Biotechnologies. MarketBeat recorded 27 mentions for Voyager Therapeutics and 11 mentions for Adverum Biotechnologies. Adverum Biotechnologies' average media sentiment score of 0.64 beat Voyager Therapeutics' score of 0.31 indicating that Adverum Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adverum Biotechnologies 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Voyager Therapeutics 2 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryVoyager Therapeutics beats Adverum Biotechnologies on 14 of the 19 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$287.88M$2.93B$5.01B$8.81BDividend YieldN/A1.89%5.16%4.06%P/E Ratio7.5545.25134.3717.77Price / Sales1.17360.241,158.6875.18Price / Cash1.74160.0933.5332.53Price / Book0.893.734.674.68Net Income$132.33M-$41.63M$119.07M$226.08M7 Day Performance-13.83%-4.73%-1.83%-1.04%1 Month Performance-30.03%-6.53%-3.62%1.04%1 Year Performance-20.12%25.63%31.63%26.28% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.6613 of 5 stars$5.36+1.7%$17.00+217.2%-21.6%$287.88M$250.01M7.55100Analyst UpgradeAnalyst RevisionGap UpADVMAdverum Biotechnologies4.1701 of 5 stars$6.17-1.3%$27.83+351.1%-32.5%$128.34M$3.60M-1.03190Analyst ForecastShort Interest ↓JNCEJounce TherapeuticsN/A$1.88-2.6%N/A+0.0%$98.94M$82M-0.73137Analyst ForecastHigh Trading VolumeCASICASI Pharmaceuticals3.7991 of 5 stars$5.22-2.2%$6.00+14.9%+0.4%$82.56M$22.06M-2.34180BLUEbluebird bio2.8596 of 5 stars$0.30flat$3.03+898.3%-92.1%$58.92M$29.50M-0.17323Analyst ForecastAGTCApplied Genetic Technologies0.1172 of 5 stars$0.39flatN/AN/A$26.62M$320,000.00-0.2783APLTApplied Therapeutics4.3431 of 5 stars$9.43+5.6%$12.50+32.6%+373.9%$1.10B$9.99M-5.8330AVDLAvadel Pharmaceuticals2.3424 of 5 stars$10.75+0.3%$24.43+127.2%-7.5%$1.03B$138.16M-13.61154Short Interest ↓ZYMEZymeworks2.8655 of 5 stars$14.55-1.5%$19.00+30.6%+74.0%$1.02B$76.01M0.00290SEPNSepternaN/A$22.50-7.0%$43.67+94.1%N/A$1.02BN/A0.00N/AAnalyst ForecastNews CoverageGap UpCOGTCogent Biosciences2.866 of 5 stars$9.08+0.2%$14.83+63.4%+20.6%$1.00BN/A0.0080Analyst Revision Related Companies and Tools Related Companies Adverum Biotechnologies Alternatives Jounce Therapeutics Alternatives CASI Pharmaceuticals Alternatives bluebird bio Alternatives Applied Genetic Technologies Alternatives Applied Therapeutics Alternatives Avadel Pharmaceuticals Alternatives Zymeworks Alternatives Septerna Alternatives Cogent Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VYGR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VYGR Stock Alerts